Clinical trial
Optimization of Dosing of Immunoglobulin G in the Obese Population
NCT04818177 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of Dosing of Immunoglobulin G in the Obese Population
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- August 1, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune deficiency, obesity